Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 10Genitourinary 9Thoracic 8Gastrointestinal 8CNS 7Head & Neck 5Sarcoma 4Lymphoid 2Gynecologic 2Endocrine 1Dermatologic 1

Conditions

Pituitary Neoplasms 1Neurilemmoma 1Nerve Sheath Neoplasms 1Meningioma 1Brain Neoplasms 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Protons × Endocrine × Clear all
NCT04278118 2026-02-17

HiPPI

Emory University

Phase NA Recruiting
70 enrolled
CNSEndocrine

Brain Neoplasms, Meningioma, Neurilemmoma, Pituitary Neoplasms, Nerve Sheath Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡